HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.

Abstract
We aimed for the comparison of two protocols (OAP and COMP) as chemotherapy treatment in children with Hodgkin lymphoma (HL). A total of 119 children newly diagnosed with HD were divided to receive either the anthracycline-based OAP protocol or the alkylating-agent-based COMP protocol. Sixty patients received the OAP protocol and 59 patients received the COMP protocol. Complete response was achieved for 81.4% of patients treated with the COMP protocol versus 53.3% for those who received the OAP treatment. Toxic hepatitis or liver cell failure was recorded in 5% of patients treated with the COMP protocol. Complications were more frequent in those treated with the OAP protocol, as 6.8% developed heart failure and 20% showed toxic hepatitis or liver cell failure. The relapse rate was almost equal in both treatment arms. Patients treated with the COMP protocol achieved a better response and less toxicity but with similar survival to those given the OAP protocol.
AuthorsYoussef Al-Tonbary, Mohamed M Sarhan, Rasha A El-Ashry, Emad Salama, Mohamed Sedki, Ashraf Fouda
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 51 Issue 4 Pg. 656-63 (Apr 2010) ISSN: 1029-2403 [Electronic] United States
PMID20218813 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cytarabine
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Cyclophosphamide
  • Prednisone
  • Methotrexate
Topics
  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects)
  • Child
  • Child, Preschool
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Cytarabine (administration & dosage, adverse effects)
  • Egypt
  • Female
  • Follow-Up Studies
  • Hodgkin Disease (drug therapy, mortality)
  • Humans
  • Infant
  • Male
  • Mechlorethamine (administration & dosage, adverse effects)
  • Methotrexate (administration & dosage, adverse effects)
  • Prednisone (administration & dosage, adverse effects)
  • Procarbazine (administration & dosage, adverse effects)
  • Survival Analysis
  • Vincristine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: